Senior insider sale
BRIDGEBIO PHARMA, INC. — senior position signals high conviction
$1.44M
17.17K shares
What this filing means
ELLIS ANDREA plans to sell 17.17K shares of BRIDGEBIO PHARMA, INC. valued at approximately $1.44M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/9/2026ACC: 0001950047-26-006976
17.17K
Shares to sell
$1.44M
Approx. market value
17.17K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
7/9/2026
17.17KTotal acquired17.17K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/9/2026 | Stock Option Exercise Cash | 17.17K | — |
| Total | 17.17K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
17.17K
Market value
$1.44M
7/9/2026
Total
Units
17.17K
Value
$1.44M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/9/2026 | 17.17K | $1.44M | NASDAQ | Planned |
| Total | 17.17K | $1.44M | ||